{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:25:38Z","timestamp":1791926738980,"version":"4.3.4"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,10]]},"DOI":"10.1097\/qad.0b013e32834a40cd","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T13:08:19Z","timestamp":1310130499000},"page":"1747-1751","source":"Crossref","is-referenced-by-count":349,"title":["CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy"],"prefix":"10.1097","volume":"25","author":[{"given":"Ronald J.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayraan","family":"Badiee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Vaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Morgello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Allen","family":"McCutchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1089\/aid.2007.0310","article-title":"Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.","volume":"24","author":"Munoz-Moreno","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":"The prevalence and incidence of neurocognitive impairment in the HAART era.","volume":"21","author":"Robertson","year":"2007","journal-title":"AIDS"},{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13550280590952790","article-title":"Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.","volume":"11","author":"Tozzi","year":"2005","journal-title":"J Neurovirol"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders.","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1258\/0956462001916551","article-title":"Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIVAIDS.","volume":"11","author":"Kalichman","year":"2000","journal-title":"Int J STD AIDS"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13550280600915339","article-title":"Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort.","volume":"12","author":"Valcour","year":"2006","journal-title":"J Neurovirol"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"CHARTER GroupValidation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system.","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e32834a40cd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:32:51Z","timestamp":1786044771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201109100-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,10]]},"references-count":8,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32834a40cd","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,10]]}}}